SLS SELLAS Life Sciences Group, Inc.
8-K Current Report
Filed: March 19, 2026
Health Care
Pharmaceutical PreparationsSELLAS Life Sciences Group, Inc. (SLS) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Earnings report covers full year ended December 31, 2025, providing latest financial performance update
- • Press release with detailed results included as Exhibit 99.1, available for investors to review key metrics and outlook
Other SELLAS Life Sciences Group, Inc. 8-K Filings
Get deeper insights on SELLAS Life Sciences Group, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.